These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11721691)

  • 1. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia: pathophysiology and therapeutic approach.
    Capozzi A; Scambia G; Pontecorvi A; Lello S
    Gynecol Endocrinol; 2015 Jul; 31(7):506-10. PubMed ID: 26291795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia].
    Oesterle M; Galeazzi RL
    Praxis (Bern 1994); 1995 Jun; 84(25-26):778-83. PubMed ID: 7597365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speed of response to dopaminergic agents in prolactinomas.
    Hage C; Salvatori R
    Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hypothyroidism presenting with amenorrhea, galactorrhea, hyperprolactinemia and enlarged pituitary].
    Tadmor OP; Barr I; Diamant YZ
    Harefuah; 1992 Jan; 122(2):76-8. PubMed ID: 1572562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia and infertility.
    Shibli-Rahhal A; Schlechte J
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):837-46. PubMed ID: 22108283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with primary hypothyroidism presenting as prolactinomas.
    Grubb MR; Chakeres D; Malarkey WB
    Am J Med; 1987 Oct; 83(4):765-9. PubMed ID: 3674063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical prolactin response to growth hormone-releasing hormone in a patient with hyperprolactinemia and empty sella.
    Imai Y; Shimizu T; Sawano S; Ozawa Y; Watanabe T; Shishiba Y
    Endocrinol Jpn; 1991 Apr; 38(2):183-6. PubMed ID: 1752237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant prolactinomas, a detailed analysis of 196 adult cases.
    Lisa B; Arno V; Christophe B; Heyning Paul V; Carlien H
    Pituitary; 2023 Oct; 26(5):529-537. PubMed ID: 37544978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of prolactin and the role of dopamine agonists: A review.
    Kirsch P; Kunadia J; Shah S; Agrawal N
    Front Endocrinol (Lausanne); 2022; 13():1002320. PubMed ID: 36246929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia after menopause: Diagnosis and management.
    Auriemma RS; Pirchio R; Pivonello R; Colao A
    Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.